Download Files:
Products Details
Product Description
– P2X3 antagonist 36 is a P2X3 antagonist extracted from patent WO2019081343A1 compound 156[1].
Web ID
– HY-143568
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C20H18ClF3N6O3
References
– [1]Koppitz M, et, al. Novel pyrazolo-pyrrolo-pyrimidine-dione derivatives as p2x3 inhibitors. WO2019081343A1.
CAS Number
– 2310263-59-1
Molecular Weight
– 482.84
SMILES
– O=C(NC1=NC=C(Cl)C=C1)CN(C2=C3CN([C@H](C)CC)C2=O)C4=CC(C(F)(F)F)=NN4C3=O
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– P2X Receptor
Isoform
– P2X3 Receptor
Pathway
– Membrane Transporter/Ion Channel
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
